BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Integra LifeSciences (NASDAQ: IART).The analyst comments "ART has been working over ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE